![Bio-Rad expands range of quality controls for Abbott clinical diagnostics platforms - Clinical Laboratory int. Bio-Rad expands range of quality controls for Abbott clinical diagnostics platforms - Clinical Laboratory int.](https://clinlabint.com/wp-content/uploads/sites/2/2023/01/biorad_intelliq.png)
Bio-Rad expands range of quality controls for Abbott clinical diagnostics platforms - Clinical Laboratory int.
![Diamet SIA | Bio-Rad VIROTROL and VIROCLEAR Serological Controls for COVID-19 Clinical Assay Testing Diamet SIA | Bio-Rad VIROTROL and VIROCLEAR Serological Controls for COVID-19 Clinical Assay Testing](http://www.diamet.lv/images/ID-HERO-after.png)
Diamet SIA | Bio-Rad VIROTROL and VIROCLEAR Serological Controls for COVID-19 Clinical Assay Testing
![Bio-Rad: A Very Interesting Short-Term Investment Thanks To Gains On Sartorius Holding (NYSE:BIO) | Seeking Alpha Bio-Rad: A Very Interesting Short-Term Investment Thanks To Gains On Sartorius Holding (NYSE:BIO) | Seeking Alpha](https://static.seekingalpha.com/uploads/2020/5/29/49171940-15907397470124712_origin.jpg)
Bio-Rad: A Very Interesting Short-Term Investment Thanks To Gains On Sartorius Holding (NYSE:BIO) | Seeking Alpha
![Bio-Rad Expands Range of Quality Controls for Abbott Clinical Diagnostics Platforms - Clinical Laboratory int. Bio-Rad Expands Range of Quality Controls for Abbott Clinical Diagnostics Platforms - Clinical Laboratory int.](https://clinlabint.com/wp-content/uploads/sites/2/2022/12/image001.jpg)
Bio-Rad Expands Range of Quality Controls for Abbott Clinical Diagnostics Platforms - Clinical Laboratory int.
![The Clinical Diagnostics division from Everlife-Chemopharm Group received two awards from Bio-Rad Southeast Asia 2023 | Articles, Event, News, Press Release, Publication | Chemopharm Group The Clinical Diagnostics division from Everlife-Chemopharm Group received two awards from Bio-Rad Southeast Asia 2023 | Articles, Event, News, Press Release, Publication | Chemopharm Group](https://www.chemopharm.com/wp-content/uploads/2023/03/BioRad_Award_24Feb2023001.jpg)
The Clinical Diagnostics division from Everlife-Chemopharm Group received two awards from Bio-Rad Southeast Asia 2023 | Articles, Event, News, Press Release, Publication | Chemopharm Group
![The Clinical Diagnostics division from Everlife-Chemopharm Group received two awards from Bio-Rad Southeast Asia 2023 | Articles, Event, News, Press Release, Publication | Chemopharm Group The Clinical Diagnostics division from Everlife-Chemopharm Group received two awards from Bio-Rad Southeast Asia 2023 | Articles, Event, News, Press Release, Publication | Chemopharm Group](https://www.chemopharm.com/wp-content/uploads/2023/03/combine001_jpeg.jpg)